Mouse PDX Trial Suggests Synergy of concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS mutations
Yao, Yung-mae M, Donoho, Gregory P., Iversen, Philip, Zhang, Youyan, Van Horn, Robert D., Forest, Amelie, Novosiadly, Ruslan, Webster, Yue, Philip, Ebert J, Bray, Steven M, Ting, Jason C., Aggarwal, ALanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-3250
Date:
June, 2017
File:
PDF, 3.12 MB
english, 2017